Of the pure-play gene editing specialists on the market, CRISPR Therapeutics (NASDAQ: CRSP) is one of the more prominent. CRISPR Therapeutics (NasdaqGM:CRSP) experienced an 12% price decline over ...

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

All claims must be made on form CAS1. Claims should be submitted electronically with supporting evidence to [email protected] within 3 months of the completed hearing, cancelled hearing, ...